| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/21/1999 | EP0930366A2 Binding domains in delta proteins |
| 07/21/1999 | EP0930365A2 Binding domains in serrate protein |
| 07/21/1999 | EP0930304A1 Process for producing cyclodepsipeptide compounds and novel cyclodepsipeptide |
| 07/21/1999 | EP0929688A1 Sustained delivery device and methods of making and using the same |
| 07/21/1999 | EP0929680A1 Thermostable dna polymerase from carboxydothermus hydrogenoformans |
| 07/21/1999 | EP0929677A2 Method for producing recombinants intended for use in a complete malaria antigene gp190/msp1 |
| 07/21/1999 | EP0929673A2 Tumor proteins |
| 07/21/1999 | EP0929672A1 Human gtp binding protein gamma-3 |
| 07/21/1999 | EP0929670A1 P-selectin ligand proteins |
| 07/21/1999 | EP0929668A1 Modulators of brca1 activity |
| 07/21/1999 | EP0929667A1 Hypertension markers |
| 07/21/1999 | EP0929664A1 Hematopoietic stem cells and methods for generating such cells |
| 07/21/1999 | EP0929579A1 Monoclonal antibodies against a human act and serine protease complex |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929576A1 Glp-2 derivatives |
| 07/21/1999 | EP0929575A1 Novel human growth factors |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929564A1 High level expression of proteins |
| 07/21/1999 | EP0929316A1 Novel product and process for t lymphocyte veto |
| 07/21/1999 | EP0629239B1 Insecticidal toxins from the parasitic wasp bracon hebetor |
| 07/21/1999 | EP0594576B1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 07/21/1999 | EP0463064B1 Neuronal nicotinic acetylcholine receptor compositions containing the beta4 subunit |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223685A Modulators of tissue regeneration |
| 07/21/1999 | CN1223549A Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 07/20/1999 | US5925742 Protein affecting KATP channels |
| 07/20/1999 | US5925741 A specific aspect of the present invention concerns bae which are revealed after virus-receptor interaction, e.g. hiv-cd4 interaction. |
| 07/20/1999 | US5925740 Antibodies to receptor for oncostatin M |
| 07/20/1999 | US5925733 DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis |
| 07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925550 Method for selectively increasing the ratio of single major components of antibiotic A/16686 complex |
| 07/20/1999 | US5925549 Soluble 7-transmembrane domain G-protein-coupled receptor compositions and methods |
| 07/20/1999 | US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins |
| 07/20/1999 | US5925539 Human pelota homolog |
| 07/20/1999 | US5925536 Receptor-type phosphotyrosine phosphatase-β |
| 07/20/1999 | US5925526 Paraneoplastic cerebellar degeneration (pcd) is a disorder of the cerebellum found in association with neoplasms usually of lung, ovary, breast, or hodgkins disease. |
| 07/20/1999 | US5925512 Monoclonal antibody which specifically binds to mutant hepatitis b virus surface antigen ?a? determinant |
| 07/20/1999 | US5925362 Method to elicit an antitumor response with human prostate-specific antigen |
| 07/20/1999 | US5925352 Administering antiinflammatory amount of anti-neutrophil chemotactic factor antibodies |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/20/1999 | US5925347 Viral vector vaccines comprising nucleic acids encoding eimeria proteins for poultry vaccination against coccidiosis |
| 07/20/1999 | CA2155001C Htlv-i and htlv-ii gp21 derived peptides for use in diagnostics |
| 07/20/1999 | CA2137638C Anti gangliosides monoclonal antibodies and their use in the specific active immunotherapy of malignant tumors |
| 07/20/1999 | CA2087730C Use of crosslinked crystals as a novel form of enzyme immobilization |
| 07/20/1999 | CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/20/1999 | CA2078725C Monoclonal antibody specific for inbred strains |
| 07/20/1999 | CA1340656C Membrane anchor/active compound conjugate, its preparation and its use |
| 07/15/1999 | WO1999035502A1 Use of mass fingerprinting for identification of protein affinity ligands |
| 07/15/1999 | WO1999035272A1 RECOMBINANT P37/FlaA AS A DIAGNOSTIC REAGENT |
| 07/15/1999 | WO1999035268A1 IL-1 delta DNA AND POLYPEPTIDES |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035265A1 Human vps35/mem3-related protein |
| 07/15/1999 | WO1999035263A2 Il-17rh dna and polypeptides |
| 07/15/1999 | WO1999035260A1 Non-identical genes and their application in improved molec ular adjuvants |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035165A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
| 07/15/1999 | WO1999035159A1 Lymphoma/leukemia oncogene, oncoprotein and methods of use |
| 07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/15/1999 | WO1999025734A3 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
| 07/15/1999 | WO1999024466A3 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
| 07/15/1999 | WO1999023867A3 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | WO1998053066A9 Smad2 phosphorylation and interaction with smad4 |
| 07/15/1999 | CA2318435A1 Human fk506 binding proteins |
| 07/15/1999 | CA2317918A1 Il-1 delta dna and polypeptides |
| 07/15/1999 | CA2317898A1 Human vps35/mem3-related protein |
| 07/15/1999 | CA2317817A1 Il-17rh dna and polypeptides |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2317020A1 Non-identical genes and their application in improved molecular adjuvan ts |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316775A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2283494A1 Recombinant p37/flaa as a diagnostic reagent |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928340A1 Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
| 07/14/1999 | EP0928339A1 Mammalian artificial chromosomes |
| 07/14/1999 | EP0928337A1 A human protein tyrosine kinase |
| 07/14/1999 | EP0928336A1 Chaperone fragments |
| 07/14/1999 | EP0928334A1 Methods for preparing synthetic repetitive dna |
| 07/14/1999 | EP0928202A1 Non-invasive administration of adeno-associated viral vectors |
| 07/14/1999 | EP0574414B1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 07/14/1999 | EP0553198B1 Regulation of immunoglobulin production by interleukin-9 |
| 07/14/1999 | EP0531434B1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/14/1999 | EP0287653B1 Hormone receptor compositions and methods |
| 07/14/1999 | CN1222936A Recombinant protein containing c-terminal fragment of plasmodium MSP-1 |
| 07/14/1999 | CN1222917A Novel protein and process for producing the same |
| 07/14/1999 | CN1222914A High molecular weight surface proteins of non-typeable haemophilus |
| 07/14/1999 | CN1044133C Process for preparing nucleotide series corresponding to human erythropoietin gene fragment |
| 07/13/1999 | US5922858 Misaminoacylated transfer ribonucleic acid with photocleavable marker; for incorporation of non-radioactive labels into nascent proteins by cellular or cell-free translation systems |
| 07/13/1999 | US5922854 Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922847 Exposure to antibody or fragments binding to epitope on receptor recognized by the factor, separating binding cells |
| 07/13/1999 | US5922846 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/13/1999 | US5922845 Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies |
| 07/13/1999 | US5922844 Human cAMP-dependent protein kinase inhibitor homolog |